IL17A and metabolic dysfunction-associated steatotic liver disease: IL-17A and IL-17F, the most studied members of the IL-17 family, play pivotal roles in MASLD by promoting inflammation, disrupting metabolic balance, and driving fibrogenesis through direct activation of hepatic stellate cells [78] (Figure 4).